ASX:TD1 (Australia)
Â
Business Description
Description
TALI Digital Ltd engaged in research and development, for commercialisation, of medical technology projects. It is a digital health company delivering diagnostic and therapeutic solutions to improve cognitive function and behavior.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.67 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -46.53 | |||||
Beneish M-Score | -4.8 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.2 | |||||
3-Year EPS without NRI Growth Rate | 5.9 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -20.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.99 | |||||
9-Day RSI | 45.57 | |||||
14-Day RSI | 47.82 | |||||
6-1 Month Momentum % | -51.99 | |||||
12-1 Month Momentum % | -85.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.43 | |||||
Quick Ratio | 3.43 | |||||
Cash Ratio | 2.47 | |||||
Days Sales Outstanding | 4061.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -50900 | |||||
Net Margin % | -44846.15 | |||||
ROE % | -113.12 | |||||
ROA % | -73.01 | |||||
ROIC % | -116.72 | |||||
ROC (Joel Greenblatt) % | -510.19 | |||||
ROCE % | -80.06 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.25 | |||||
EV-to-EBIT | -0.97 | |||||
EV-to-EBITDA | -1.04 | |||||
EV-to-Revenue | 430.38 | |||||
EV-to-FCF | -1.29 | |||||
Earnings Yield (Greenblatt) % | -103.09 |